Back
ESC Professional Premium Access

Deterioration of cardiogenic shock after acute myocardial infarction defined by the society for cardiovascular angiography and intervention cardiogenic shock classification scheme

Session: Complicated acute coronary syndromes issues
Topic: Shock
Speaker: Doctor T. Mukaida (Osaka, JP)
Event: ESC Congress 2022

Congress Presentation

Add to my library

Like

About the speaker

Doctor Takuto Mukaida

National Cerebral and Cardiovascular Center Hospital, Osaka (Japan)
0 follower

6 more presentations in this session

Prognostic impact of plasma glucose on cardiogenic shock patients with or without diabetes ellitus: smart rescue trial

Speaker: Doctor S. Choi (Incheon, KR)

Access
Abstract
Slides
Like
Thumbnail

Temporal trend mortality and in-hospital mortality predictors in an ischemic cardiogenic shock population: a 10 years single-centre retrospective study.

Speaker: Doctor L. Belfioretti (Ancona, IT)

Access
Abstract
Slides
Like
Thumbnail

Cardiac rupture after ST elevation myocardial infarction - a decade s experience of a tertiary cardiology centre

Speaker: Doctor C. Margineanu (London, GB)

Access
Abstract
Slides
Like
Thumbnail

One-year unplanned readmission after percutaneous coronary intervention in ST-elevation myocardial infarction: rates, causes and predictors

Speaker: Doctor O. Alkhalaila (Doha, QA)

Access
Abstract
Slides
Like
Thumbnail

PARADISE-MI - event rates and treatment effect of sacubitril/valsartan v ramipril by the presence or absence of transient pulmonary congestion and/or LVEF less or greater than 40

Speaker: Professor M. Petrie (Glasgow, GB)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Complicated acute coronary syndromes issues

Speakers: Doctor T. Mukaida, Doctor S. Choi, Doctor L. Belfioretti, Doctor C. Margineanu, Doctor O. Alkhalaila...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources